Global Regenerative Medicine Market was valued at US$ 29.1 billion in 2019 and is anticipated to reach US$ 178.6 billion by 2031 displaying reasonable CAGR of 31.5% over the forecast period (2020-2026). Regenerative Medicine refers to a group of biomedical approaches to clinical therapies that may involve the use of stem cells. The market of the Regenerative medicine market is anticipated to grow enormously owing to factors such as the growing prevalence of genetic disorders and chronic diseases, the rising pipeline of the regenerative medicine products, and technological advancements in the regenerative medicine field. Increasing the adoption of stem cell technologies, gene therapies, and tissue engineering for treating conditions such as blood cancer and other hematologic conditions is driving the industry growth. The potential application of cell therapy includes treatment for urinary problems, cancers, repairing spinal cord injuries, autoimmune disease, rebuilding damaged cartilage in joints, immune system improvement, neurological disorders and infectious disease. The increasing prevalence of chronic conditions, government assistance and numerous companies investing heavily in stem cell therapy research and development, thereby boost the overall market growth. The rising number of organ transplantation and an increasing number of products in the pipeline mark as an opportunity for this industry. However, the high cost associated with regenerative medicine and Ethical Issues related to the use of stem cell & regenerative medicines acts as the major challenges in the growth of this market.
“Cell therapy regenerative medicine dominated the market, with a 60% share in 2022”
Based on product type, the global regenerative medicine market is bifurcated into Cell therapy, gene therapy, tissue engineering and small molecule and biologics. The market of the Cell therapy segment was expected to grow tremendously and is projected to dominate the market in 2026 due to the technological advancements coupled with increasing utilization of cell therapy as a treatment to several conditions. Tissue Engineering segment is expected to generate revenue of US$ 52.2 billion by 2031. However, the Gene Therapy segment is expected to witness the highest CAGR growth of 33.9% during the forecast period 2022-2031.
Get a Sample Copy of this Report with Graphs and Charts: https://www.sdki.jp/sample-request-111474
“Biologically Derived Materials dominated the material type segment, generating revenue of US$ 16.59 billion in 2022”
Based on material type the global Regenerative Medicine market is segmented into synthetic materials, biologically derived materials, genetically engineered materials and others (pharmaceuticals). The Biologically Derived Materials occupied the largest share and is expected to maintain its dominance throughout the forecast period 2022-2031 owing to the increased usage and advancements in biologically derived materials. Synthetic Materials segment is expected to generate revenue of US$ 57.51 billion by 2026. Genetically Engineered Materials segment is expected to witness the highest CAGR growth of 33.9% during the forecast period.
“In 2019, Regenerative medicine was majorly used for the treatment of Oncology disorder”
Cardiovascular, Oncology, Dermatology, Musculoskeletal, Immunology and Inflammation, Ophthalmology, Neurology, Others are the major application of Regenerative medicine. The application of regenerative medicine for the treatment of Oncology disorder generated revenue of US$ 15.50 billion in 2022. However, the application of regenerative medicine for the treatment of Neurology disorder is expected to witness the highest CAGR growth of 33.0% during the forecast period. Musculoskeletal segment is expected to generate revenue of US$ 12.50 billion by 2031.
“North America dominates the global Regenerative Medicine market”
For better understanding of the overall adoption rate of regenerative medicine in major markets, detailed country-level analysis has been conducted for major regions/countries including North America (US, Canada, Rest of North America), Europe (UK, Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, Australia and South Korea, Rest of Asia-Pacific), and the Rest of the World (Brazil, South Africa and others). Based on the estimation, North America dominated the global Regenerative Medicine Market, generating revenue of US$ 12.10 billion in 2019. The increasing demand for regenerative medicine in the treatment of chronic diseases, cancer, and enhancement in nanotechnologies would drive the market for regenerative medicine in the North American region.
Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-111474
Competitive Landscape-Top Market Players
Some of the major players profiled in the study includes Athersys, Inc., Corline Biomedical AB, Mesoblast, Nuvasive, Inc., Cook Biotech, Integra LifeSciences Corporation, Organogenesis, Osiris Therapeutics, Inc., Stryker Corporation, U.S. Stem Cell, Inc., Spark Therapeutics, Pfizer, REGENXBIO, Abbott Laboratories, Roche, Sarepta Therapeutics, Gilead Sciences. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.
Reasons to buy:
• Current and future market size from 2019 to 2026 in terms of value (US$)
• Combined analysis of deep dive secondary research and input from primary research through Key Opinion Leaders of the industry
• Country-level details of the overall adoption of the regenerative medicine market
• A quick review of overall industry performance at a glance
• In-depth analysis of key industry players
• A detailed analysis of regulatory framework, drivers, restraints, key trends and opportunities prevailing in the industry
• Examination of industry attractiveness with the help of Porter’s Five Forces analysis and start-ups
• The study comprehensively covers the market across different segments and sub-segments of the technology
• Region/country Covered: North America (US, Canada, Rest of North America), Europe (UK, Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, Australia and South Korea, Rest of Asia-Pacific), and the Rest of the World (Brazil, South Africa and others)
UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Regenerative Medicine Market can be customized to the country level or any other market segment.
Close-in Weapon Systems Market
Asia-Pacific Freighter Aircraft Market
Asia-Pacific Light and Very Light Jets Market
Pressure Gauge Market
Explosive Ordnance Disposal Market
Asia-Pacific Tactical UAV Market
America Freighter Aircraft Market
Naval Navigation and Communication Systems Market
Anti-Submarine Warfare Market
Middle-East and Africa Armored Vehicles Market
Europe Business Jet Market
Southeast Asia Defense Market
America Airport Passenger Screening Systems Market
Europe Airport Passenger Screening Systems Market
Middle-East and Africa Airport Ground Handling Systems Market
Asia-Pacific Drones Market